Alphabet’s earnings report, due after the close of trading on Tuesday, should provide fresh evidence on the current state of the digital advertising environment—as well as important data points on the strength of the cloud computing business. Analysts are optimistic on both fronts.
Likewise, Wedbush analyst Scott Devitt wrote in a recent research note that the setup for digital advertising plays remains positive for the second half, with growth rates continuing to accelerate. He also sees potential for operating margin leverage from cost cuts tied to recent staff reductions. Another focus for investors will be how YouTube’s debut this season of its NFL Sunday Ticket football package is being received by consumers—and whether it is boosting uptake for the YouTube TV subscription service. And of course there will be multiple questions on the call about how generative artificial intelligence—like the company’s Bard chatbot—are impacting both costs and revenue.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Nasdaq 100, S&P 500 Weekly Forecast: Alphabet, Microsoft and Amazon Earnings EyedCorporate earnings from tech mega-caps Alphabet, Microsoft, and Amazon could guide market sentiment and set the trading tone for the S&P 500 and Nasdaq 100 in the coming week.
続きを読む »
Dow futures lift, Alphabet and Microsoft earnings in focusDow futures lift, Alphabet and Microsoft earnings in focus
続きを読む »
Tech's Biggest Earnings Week Is HereMicrosoft and Alphabet kick off a big week of Big Tech earnings Tuesday.
続きを読む »
GE Earnings Are Coming. What to Expect.Investors will be looking for a guidance boost and an update on the GE Vernova spinoff.
続きを読む »
Alphabet Inc. Cl A stock rises Monday, outperforms marketSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
続きを読む »
Chevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease...
続きを読む »